A Medical Review Officer (MRO) must independently verify every positive drug test before it is reported as a violation. The MRO interviews the employee, checks for legitimate medical explanations such as a valid prescription, orders a confirmatory laboratory test on the split specimen when needed, and then reports a verified result to the employer. That verification step is the core legal duty, and it separates a laboratory result from an actionable finding.
The MRO is a licensed physician who holds a certification recognized under federal workplace drug-testing rules. The role exists because a lab detects molecules, not context. An immunoassay screen can flag a compound that a physician legally prescribed, or a food that produced a false signal. The MRO's job is to insert clinical judgment and due process between the vial and the personnel file.
This explainer walks through the mechanism, the regulatory thresholds, the edge cases that trip up employers, and the concrete actions an MRO takes at each stage.
The verification mechanism: from lab result to defensible finding
The chain starts when a laboratory reports a specimen as positive. Under the federal model, the lab first runs an initial immunoassay and then confirms any presumptive positive with a second, more specific method, typically gas chromatography-mass spectrometry or liquid chromatography-tandem mass spectrometry. Only after that confirmation does the result reach the MRO.
The MRO then conducts a confidential interview with the employee. The purpose is narrow and specific: to determine whether there is a legitimate medical explanation for the confirmed result. The MRO asks about prescription medications, current treatment, and relevant medical conditions. The MRO does not counsel the employee, does not treat addiction, and does not decide discipline.
If the employee presents a valid prescription from a licensed practitioner for a drug the MRO reasonably determines was used as prescribed, the MRO reports the result as negative. If no legitimate explanation exists, the MRO reports it as verified positive. The employer receives the verified determination, not the raw lab value.
A key structural detail: the MRO is the only party authorized to convert a laboratory positive into an employer-facing result. The lab cannot report directly to the employer, and the employer cannot reinterpret the lab finding. This firewall protects both the employee's medical privacy and the integrity of the process.
Quantified context: cutoffs, timelines, and testing volume
Federal workplace testing uses defined cutoff concentrations. For amphetamines and methamphetamine, the confirmatory cutoff is typically 500 ng/mL; for cocaine metabolite (benzoylecgonine), 150 ng/mL; for opiates, 2,000 ng/mL; for marijuana metabolite, 15 ng/mL; and for phencyclidine, 25 ng/mL. These are confirmatory thresholds, not screening thresholds, and they are set to distinguish incidental exposure from substantive use. A value at or above the cutoff is reported as positive by the lab.
Timing matters. The MRO generally must contact the employee promptly after receiving a confirmed positive, and federal rules require the verification interview to occur before the result is reported. If the employee cannot be reached, the MRO documents attempts and follows an established escalation sequence. The split specimen, a second portion of the same sample, remains available for independent retesting at the employee's request, usually within 72 hours of notification.
Volume gives context to the workload. Federal drug-testing programs process millions of specimens annually, and the majority return negative. Among confirmed positives, a meaningful share are ultimately verified as negative by the MRO because of legitimate prescriptions, most often for opioids, amphetamines, or benzodiazepines. The MRO's review is therefore not a rubber stamp; it changes the outcome in a nontrivial fraction of positive cases.
Timeline of MRO actions after a confirmed positive
| Stage | Typical timing | MRO action |
|---|---|---|
| Lab confirmation received | Day 0 | Review chain-of-custody, confirm cutoff met |
| Employee contact attempt | Within 1 business day | Schedule confidential interview |
| Verification interview | Within a few business days | Ask about prescriptions, medical conditions |
| Documentation review | Same day to a few days | Verify prescription validity with prescriber or pharmacy |
| Split specimen request window | Usually 72 hours from notice | Advise employee of retest right |
| Final determination | After interview and documentation | Report verified positive or negative to employer |
The exact intervals depend on the applicable program and the employer's policy. Federal rules and private-sector policies differ, so the MRO works to the governing standard, not a universal clock.
Edge cases that determine the outcome
Several situations require the MRO to reason carefully rather than apply a rule mechanically.
Prescription legitimacy is the most common. A valid prescription for a controlled substance generally converts a positive to negative, but the MRO must confirm the prescription is current, issued by a practitioner authorized to prescribe, and consistent with the detected drug. A prescription for a different drug, an expired prescription, or a prescription obtained fraudulently does not qualify.
The split specimen request is a procedural right. If the employee disputes the result, the MRO arranges independent testing of the split specimen at a different certified laboratory. A failure to confirm on the split specimen invalidates the original positive. This is a genuine check on laboratory error, not a formality.
Adulteration and substitution raise separate questions. If the lab reports that the specimen was diluted, substituted, or adulterated, the MRO evaluates whether the employee had a legitimate medical explanation, such as a prescribed diuretic. Otherwise the result is treated as a refusal to test, which carries its own consequences distinct from a positive.
Legitimate medical use of marijuana is the sharpest edge case. Under federal rules, marijuana remains a prohibited substance regardless of state medical or recreational legality, and the MRO cannot accept a state-issued marijuana authorization as a legitimate medical explanation for a federal test. Employers with private policies may set different rules, and the MRO follows the governing standard for that program.
A confirmed positive with a valid, current prescription for the detected drug generally becomes a verified negative. A confirmed positive with no explanation, or with an invalid prescription, becomes a verified positive. A split specimen that fails to confirm invalidates the original result. A specimen reported as substituted or adulterated is handled as a refusal, not a positive. State marijuana authorization does not excuse a federal positive, though private policies vary.
Common misconceptions about the MRO role
The most persistent misconception is that the MRO decides discipline. The MRO does not. The MRO reports a verified result, and the employer applies its own policy, collective bargaining agreement, or regulatory consequence. Confusing the two roles leads employees to argue their case to the wrong party and leads employers to expect a recommendation the MRO cannot give.
A second misconception is that a positive screen is a positive result. Screening immunoassays are deliberately sensitive and produce cross-reactivity. The confirmatory test and the MRO review are what make a result defensible. Treating a screen as final is both clinically and legally premature.
A third misconception is that the MRO can override a laboratory finding on technical grounds. The MRO can evaluate medical explanations and order a split-specimen retest, but the MRO does not re-run the original analysis or substitute personal judgment for the lab's validated method.
A counterintuitive professional caveat: an MRO who finds no legitimate explanation is not required to determine that the employee used the drug recreationally or impaired. The MRO verifies that the confirmed result lacks a legitimate medical explanation. Impairment, fitness for duty, and cause are separate determinations that belong to other processes.
Practical actions and thresholds for employers and MROs
For the MRO, the workflow is sequential and documented. Contact the employee through the established channel. Conduct the interview in private and explain the purpose. Ask specifically about prescriptions and medical conditions. Verify prescription details with the prescriber or a prescription monitoring program where authorized. Document the rationale for the determination. Report only the verified result to the employer.
For the employer, the practical actions are to designate a qualified MRO before testing begins, to keep the MRO firewall intact so raw results do not leak into supervisor channels, and to align written policy with the governing standard. The employer should also know the split-specimen window and preserve the employee's ability to exercise it.
Thresholds to keep straight: the confirmatory cutoffs above define a lab positive; the MRO's verification defines an employer-facing result; the split-specimen request window defines the employee's retest right; and the applicable program's rules define the refusal-to-test consequences. Reconciling these explicitly prevents the common error of treating a lab cutoff as a policy threshold, or a policy threshold as a lab cutoff. They are different instruments serving different purposes.
Limitations and what the MRO process cannot do
The MRO process verifies whether a confirmed result has a legitimate medical explanation. It does not establish impairment at the time of testing, does not determine cause, and does not assess fitness for duty. A verified positive is a finding about the specimen, not a clinical diagnosis and not proof of workplace impairment.
The process also depends on accurate disclosure. An employee who withholds a valid prescription at the interview may receive a verified positive that a later review would have reversed. Timing and honesty in the interview matter, and the MRO can only weigh what is presented or verifiable.
Finally, standards vary by program. Federal rules, Department of Transportation requirements, and private employer policies differ in cutoffs, refusal definitions, and marijuana treatment. The MRO applies the standard governing the specific test, so employers should confirm which framework applies before assuming a particular outcome.
This article is general educational information about the Medical Review Officer verification process. It is not a legal opinion, a diagnosis, a treatment plan, or a substitute for advice from a qualified attorney or physician familiar with your jurisdiction and program. Readers facing an actual testing dispute or disciplinary matter should consult a licensed local professional.